Pfizer: Patent Case Now Moot

Pfizer, Inc. has aked the Supreme Court to conclude that Apotex v. Pfizer, a high-profile case in the fight over pharmaceutical patents now pending before the Supreme Court, is moot. An electronic copy of the mootness suggesiton can be downloaded here, and the original petition, brief in opposition, and reply brief can be found at this post on the Orange Book Blog.

The case gained added prominence when, on May 15 of this year, the Supreme Court asked for the views of the Solicitor General. That amicus brief has not been filed.

The Court will consider whether to accept the suggestion of mootness, which Apotex opposes, during its Conference on October 6.